Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.00 (0.00%)
Bid:
102.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £61.92m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Directorate Change

7 Dec 2017 07:00

Crystal Amber Fund Limited - Directorate Change

Crystal Amber Fund Limited - Directorate Change

PR Newswire

London, December 6

7 December 2017

Crystal Amber Fund Limited

(the “Company”)

Directorate Change

The Board of Crystal Amber Fund Limited is pleased to announce the appointment of Fred Hervouet as a Non-executive Director of the Company with immediate effect.

Fred Hervouet has 20 years’ experience of working in different areas of the Financial Markets and Asset Management Industry. His experience includes Fixed Income and Derivatives Markets, Structured Finance/Project Finance, Structured Products, and Commodity Markets, Hedge Funds, Trading and Risk Management. Prior to moving to Guernsey in January 2014, he was Managing Director and Head of Commodity Derivatives Asia for BNP Paribas including Trading, Structuring and Sales. He holds a number of non-executive director positions including Funding Circle SME Income Fund Limited and Toro Limited, where he is chairman. He holds a Master Degree in Financial Markets, Commodity Markets and Risk Management from University Paris Dauphine and an MSc in Applied Mathematics and International Finance. He is a member of the UK Institute of Directors, of the UK Association of Investment Companies, of the Guernsey Chamber of Commerce and of the Guernsey Investment Fund Association.

Commenting on the appointment of Fred Hervouet as a Non-executive Director, Chris Waldron (Non-executive Chairman) said:

My fellow directors and I are very pleased to welcome Fred as a member of the Board. He brings a wealth of investment experience and we look forward to working with him.”

For further enquiries please contact: Crystal Amber Fund Limited Chris Waldron (Chairman) Tel: 01481 716 000 www.crystalamber.com Allenby Capital Limited - Nominated Adviser David Worlidge/James Thomas/Liz Kirchner Tel: 020 3328 5656 Winterflood Investment Trusts - Broker Joe Winkley/Neil Langford Tel: 020 3100 0160 Crystal Amber Advisers (UK) LLP – Investment Adviser Richard Bernstein Tel: 020 7478 9080

Appendix

Frederic Michel Hervouet, aged 44, is, or has been within the last five years, a director or partner in the following companies and partnerships:

Current directorships and partnershipsPast directorships and partnerships held within the last five years
Tetragon Group Master Fund Limited Tetragon Financial Group Limited Lakestar (G.P) Limited Lakestar II (G.P.) Limited BCGSS 2 Guernsey Ltd – Babson Capital Global Special Situations Credit 2 Chenavari Toro Income Fund Limited Funding Circle SME Income Fund Limited Terra Firma Holdings Limited Terra Firma Investments (GP) 2 Limited Terra Firma Investments (GP) 3 Limited Terra Firma Investments Limited Terra Firma Investments (Support Capital) Limited Terra Firma Executive Investments (GP) Limited Terra Firma DA Assignment CO Limited TF Executive Investments 2 Limited Terra Firma Capital Investment (GP) Limited London 58 Limited Island Sky Holdings Limited Island Sky 2 (Guernsey) Limited Terra Firma Investments 3 Limited Terra Firma Capital Advisers Limited Terra Firma Investments (Special Opportunities Fund I) Annington Holdings Guernsey Limited Terra Firma 3 Limited Island Sky Investment Limited TFSC Olymp Limited Terra Firma Investments (GP) 6 Limited Terra Firma Investments (Special Opportunities Fund II) TFSC Topaz Limited Lakestar III (GP) Limited Lakestar Growth I (GP) Limited Lakestar II Limited (partnership)HIG Global Corporate Credit Fund Limited Brightwood US Middle Market Credit Fund Ltd. Terra Firma Azzurra Holdings Limited Terra Firma Investments (RE) Limited

There are no other disclosures in accordance with Schedule 2(g) of the AIM Rules.

Date   Source Headline
22nd May 20261:07 pmRNSMonthly Net Asset Value
6th May 202612:54 pmRNSPurchase of Ordinary Shares by Tarncourt
30th Apr 20265:00 pmRNSTotal Voting Rights
22nd Apr 20262:54 pmRNSMonthly Net Asset Value
22nd Apr 20269:47 amRNSResult of EGM
16th Apr 20265:19 pmRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20265:03 pmRNSTransaction in Own Shares and Total Voting Rights
8th Apr 202610:51 amRNSTransaction in Own Shares and Total Voting Rights
1st Apr 20265:41 pmRNSDirector/PDMR Shareholding
31st Mar 20265:00 pmRNSTotal Voting Rights
31st Mar 20267:01 amRNSHalf-year Report
31st Mar 20267:00 amRNSPosting of Circular and Notice of EGM
26th Mar 20264:25 pmRNSMonthly Net Asset Value
16th Mar 20264:29 pmRNSNotice of results; update re strategy and manager
2nd Mar 202611:49 amRNSMonthly Net Asset Value
2nd Mar 202611:30 amRNSTotal Voting Rights
25th Feb 20266:17 pmRNSTransaction in Own Shares and Total Voting Rights
24th Feb 20265:26 pmRNSTransaction in Own Shares and Total Voting Rights
20th Feb 20265:44 pmRNSTransaction in Own Shares and Total Voting Rights
18th Feb 20265:04 pmRNSTransaction in Own Shares and Total Voting Rights
16th Feb 20264:04 pmRNSUpdate on Morphic Medical Inc.
13th Feb 20265:21 pmRNSTransaction in Own Shares and Total Voting Rights
12th Feb 20264:58 pmRNSTransaction in Own Shares and Total Voting Rights
11th Feb 20265:02 pmRNSTransaction in Own Shares and Total Voting Rights
10th Feb 20265:29 pmRNSTransaction in Own Shares and Total Voting Rights
9th Feb 20265:40 pmRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20266:24 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Feb 20265:59 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Feb 20266:20 pmRNSTransaction in Own Shares and Total Voting Rights
30th Jan 20265:30 pmRNSTotal Voting Rights
29th Jan 20265:18 pmRNSTransaction in Own Shares and Total Voting Rights
29th Jan 202610:38 amRNSMonthly Net Asset Value
27th Jan 20269:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20265:21 pmRNSTransaction in Own Shares and Total Voting Rights
19th Jan 20266:17 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jan 202612:32 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jan 202612:18 pmRNSReplacement: Update and corrections regarding TVRs
16th Jan 20267:00 amRNSUpdate & corrections regarding total voting rights
16th Jan 20267:00 amRNSReplacement: Transaction in Own Shares and TVR
12th Jan 20265:46 pmRNSCancellation of treasury shares
6th Jan 20265:18 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jan 20265:31 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Dec 20251:30 pmRNSTotal Voting Rights
31st Dec 20251:30 pmRNSTotal Voting Rights
29th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Dec 20254:48 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.